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ABSTRACT
Posttraumatic stress disorder (PTSD) is highly prevalent in military populations, and is
associated with significant medical costs. Due to these high costs and corresponding health
infrastructure required to meet the needs of military service personnel, it is essential that the most
effective and efficient treatments be implemented. Exposure therapy (EXP) is one of the most
widely used and empirically supported treatments for PTSD; however, some researchers have
questioned its efficacy with specific populations and in targeting specific symptoms. One such
symptom, guilt, has garnered increased attention in the PTSD treatment literature, as it is
associated with worse symptomatology and outcomes. The current study examined cognitive
changes in guilt in response to Intensive (3-week) and standard (17-week) Trauma Management
Therapy (TMT) and the impact of these cognitions on the mechanisms underlying TMT
treatment. Sample size for these analyses varied by the measure being considered. 102
individuals completed the PCL-M, 42 individuals completed the TRGI, and 39 individuals
completed the CAPS supplemental guilt items. Results suggest that a secondary benefit in guilt
symptoms is achieved by targeting anxious-related distress with exposure therapy. Furthermore,
in this sample guilt did not seem to inhibit the mechanisms or effectiveness of exposure therapy.
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CHAPTER ONE: INTRODUCTION
The treatment of posttraumatic stress disorder (PTSD) is a significant public health
concern for veteran affairs organizations and national healthcare policy. Approximately 15
percent of all returning veterans will be diagnosed with PTSD at some point in their lives
(Richardson, Frueh, & Acierno, 2010), and the USDVA (2014) reported that PTSD is the
most common diagnosis among the more than 550,000 Operation Enduring
Freedom/Operating Iraqi Freedom (OEF/OIF) veterans that received a psychiatric diagnosis
at VA facilities. The cost of providing mental health services for these veterans is
substantial, exceeding six billion dollars two years post-deployment when PTSD and
comorbid depression are considered together (Tanielian & Jaycox, 2008, as cited in Gates et
al., 2012). Furthermore, the median public health care cost for PTSD is approximately $12,000
per veteran annually (Watkins et al., 2011). This substantial cost is largely attributable to the
significant health care utilization and lost work productivity associated with PTSD (Asnaani,
Reddy, & Shea, 2014; Frayne et al., 2011; Tuerk et al., 2012).
When considering the high prevalence and significant cost associated with PTSD, the
identification of efficacious, effective, and efficient interventions is crucial to alleviate the
substantial strain on health care services. Furthermore, the effective utilization of health care
providers and organization resources can help alleviate some of the burden from already
overwhelmed facilities (Maguen et al., 2012; Roshenheck & Fontana, 2007). One way to achieve
these goals is to ensure that healthcare providers are implementing the most empirically
supported interventions and targeting the symptoms underlying the patient’s distress. The
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process of treatment and resource allocation can be greatly informed by a better understanding of
mechanisms underlying improvement in therapy.
One of the most studied and empirically supported interventions for PTSD is exposure
therapy (EXP). Recent studies have shown that EXP can be extremely efficient, as it remains
efficacious in intensive short-duration treatment formats (Beidel et al., 2014) and with shorter
individual sessions (Nacasch et al., 2015). EXP is based on Emotional Processing Theory (EPT),
the foundations of which are rooted in early animal research theorizing that the acquisition of
fear occurs through the repeated or intensive pairing of an unconditioned aversive stimulus and a
neutral or conditioned stimulus (CS) (Mowrer, 1939). Inspired by this early animal research and
information processing theories proposed by Lang (1979) and Rachman (1980), Foa and Kozak
(1986) postulated that the extinction of pathological human fear can be achieved through
repeated exposure to the fear/anxiety-provoking stimuli (CS) in the absence of aversive
consequences. This repeated exposure allows for new learning to occur that overrides previous
paired CS/US associations. Decreases in anxious responses that occur during an EXP session are
termed within-session habituation, whereas anxiety reduction that occurs across EXP sessions is
referred to as between-session habituation.
In addition to providing incompatible information to form new non-fear oriented
associations in memory, EPT posits that the fear memory structure needs to be sufficiently
activated (i.e. fear activation) for EXP to be effective. The importance of fear activation and the
formation of new inhibitory associations in predicting treatment outcome has been supported by
several studies that include physiological, neurological, and subjective measures of anxiety
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(Beidel, Turner, & Dancu, 1985; Borkovec & Sides, 1979; Foa, Riggs, Massie, & Yarczower,
1995; Minnen & Hagenaars, 2002, Pitman et al., 1996).
Randomized-controlled trials have repeatedly demonstrated the efficacy of EXP for
PTSD (Benish, Imel, & Wampold, 2008, Powers et al., 2010, Rothbaum et al., 2014) and
previous research has supported the tenets of EPT by linking improvement in PTSD symptoms to
habituation (Foa & Chambless, 1978; Jaycox, Foa, & Morral, 1998; Minnen & Hagenaars, 2002)
and fear activation (Minnen & Hagenaars, 2002; Pitman, 1996). Habituation is most commonly
defined as a significant reduction in Subjective Units of Distress (SUDS) ratings provided by the
patient over the course of imaginal exposure therapy sessions. Researchers have demonstrated
that greater reduction in peak SUDS ratings over the course of treatment is an indicator of
treatment response and is associated with greater symptom improvement (Bluett et al., 2014;
Gallagher & Resick, 2012; Rauch, Foa, Furr, & Filip 2004; Minnen & Foa, 2006).
Although EXP is a well-supported intervention for PTSD, EXP is not associated
with universal improvement, as a portion of individuals see minimal or no symptom
reduction as a result of EXP (Bradley et al., 2005; Roberts, Kitchiner, Kenardy, & Bisson,
2009; Rothbaum et al., 2014). Further, the percentage of treatment non-responders appears
to be larger in military samples (Steenkamp, Litz, Hoge, & Marmar, 2015), a problem that
is compounded by the significant dropout rates (17-52 percent) observed in this population
(Gros et al., 2011; McLay et al., 2011; Reger et al., 2011; Strachan et al., 2012; Tuerk et al.,
2010; Tuerk et al., 2011). Overall, meta-analytic studies have shown that EXP is associated
with moderate effect sizes and some studies suggest that it may not adequately address all
symptoms of PTSD (Owens, Chard, & Cox, 2008; Resick et al., 2002) or adequately target
3

all maladaptive psychological consequences of combat exposure (Litz et al., 2009). These
results have led some to suggest that the mechanisms underlying exposure therapy are
insufficient to address internalizing symptoms related to PTSD and propose alternative
interventions such as Cognitive Processing Therapy (CPT) (Resick & Schnicke, 1993) and
Imagery Rescripting (IR) (Smucker & Dancu, 1999).
Given that the theoretical underpinnings of EPT are largely based in animal research, it is
generally assumed that improvement in EXP involves the exclusive recruitment of basic neural
processes. This assumption is supported by some neurological research that links improvement
in EXP to reduced amygdala and related medial prefrontal cortex activation (Ledoux, 1996;
Phelps, Delgado, Nearing, & LeDoux, 2004; Repa et al., 2001). However, recent research
suggests that extinction learning may involve more complex higher order cognitive processes
that are essential to recovery (Hofman, 2008; Lovibond, 2004). In a review of the cognitive
processes during fear acquisition and extinction learning, Hofman (2008) points to several
studies that support the mediating role of higher order cognitive processes in extinction learning
and in the pathogenesis of anxiety disorders such as social anxiety disorder and PTSD.
Correspondingly, recent studies have demonstrated that changes in maladaptive trauma-related
cognitions precede changes in other PTSD symptoms during EXP (Oktedalen, Hoffart, &
Landkaas, 2015; Zalta et al., 2014).
In recent years, trauma-related cognitions associated with PTSD received increased
empirical attention and numerous studies have identified a trauma-specific profile of maladaptive
cognitions associated with greater functional impairment, symptom severity, and illness duration
(Friedman et al., 2013; Meiser-Stedman et al., 2009; Moser et al., 2007). In addition, Litz and
4

colleagues (2009) have introduced the concept of moral injury (i.e., a violation of personal moral
standards) specifically related to combat trauma and associated with negative outcomes and
internalizing symptoms (e.g., guilt & shame). Because of the increased attention and support for
the role of cognitive processes in PTSD, the latest revision to the Diagnostic and Statistical
Manual of Mental Disorders (DSM) diagnostic criteria for PTSD included, among other changes,
a subset of symptoms termed “negative alterations in cognitions and mood” (American
Psychiatric Association, 2013). Three of these symptoms are entirely new to the DSM and reflect
the presence of perceived internal threat such as guilt, shame, or general inferiority.
Prior to the most recent DSM revision, PTSD had largely been considered an anxiety
disorder that represented continued fear of external threat and perceived danger primarily
maintained through the avoidance of anxiety-provoking stimuli. However, there is an emerging
consensus in the literature that traumatic experiences can also elicit a diverse set of internalizing
emotions such as guilt, shame, and anger (Litz et al., 2009; Power & Fyvie, 2013). Newer
theories have broadened the conceptualization of PTSD to account for these emotions; positing
that an internal threat to an individual’s sense of self is a primary mechanism for maintaining
PTSD (Harmen & Lee, 2010). The association between guilt and PTSD is particularly strong
among veteran populations, which may be attributable to the unique types of traumatic events
related to combat that can elicit both anxious and affective emotional responses (Pugh, Taylor, &
Berry, 2015).
To this end, there is a burgeoning body of literature that acknowledges the diverse
psychological harm that can occur as a result of combat exposure. This psychological harm can
stem from traumatic events that involve intense fear and helplessness, as well as morally
5

injurious events involving perceived moral transgressions (Bryan et al., 2013; Steenkamp, Nash,
Lebowitz, & Litz, 2013; Stein et al., 2012). Although guilt and shame have long been
acknowledged as negative psychological consequences stemming from wartime violations of
personal moral standards (Hayley, 1974; Rivers, 1918), specific treatment strategies to address
these symptoms have been notably absent. Additionally, the tendency for existing treatments to
emphasize the reduction of external threat may partially explain the higher rates of treatment
non-responders in veteran samples (Steenkamp, Litz, Hoge, & Marmar, 2015).
Specifically, the emotional experience of guilt has been the subject of considerable
debate regarding its relationship to maladaptive outcomes (Tilghman-Osbrone et al., 2010) and
response to existing PTSD treatments (Rauch, Smith, & Duax, 2013; Smith, Duax & Rauch
2013; Steenkamp, Nash, Lebowitz, & Litz, 2014). Interestingly, guilt is not exclusively linked to
negative outcomes. Some theorists highlight the adaptive nature of guilt, as it promotes
reconciliation and maintains social relationships (Tanney et al., 2007). Tilghman-Osborne and
colleagues (2010) emphasize the importance of clearly defining guilt and suggest that it is
essential to differentiate guilt, which focuses on real or perceived misdeeds related to a specific
behavior or set of behaviors, from shame. Shame is a more complex emotion as it is associated
with persistent negative self-appraisal and perceived inferiority or judgment from others
potentially leading to self-isolation and social withdrawal. Furthermore, guilt can be maladaptive
if it co-occurs with shame or reinforces negative self-appraisals (Tanney et al., 2007).
In veteran populations, definitions of guilt consistent with the definition provided by
Tilghman-Osborne and colleagues (2010) is associated with negative outcomes including
depression and a higher risk of suicidal behavior (Bryan et al., 2014; Hendin, 1991; Hening et
6

al., 1997). Researchers have suggested that guilt may hinder natural emotional processing of
traumatic events and inhibit the integration of perceived misdeeds into prior belief systems
(Ehlers & Steil; Pitman et al., 1991 as cited in Pugh, Taylor, & Berry, 2015), resulting in
avoidance and the reinforcement of trauma-related psychopathology (Held et al., 2011; Street et
al., 2005). Specifically, guilt cognitions associated with a preventability, personal responsibility,
and lack of justification were most strongly associated with intrusive PTSD symptoms, whereas
preventability and personal responsibility were also related to avoidance (Pugh, Taylor, & Berry,
2015). In a review of the literature concerning guilt and PTSD, Pugh and colleagues (2015) cite
evidence for the mediating role of avoidance between guilt and PTSD, suggesting that treatments
such as EXP directly targeting avoidance may see a secondary benefit of reducing guilt
cognitions.
Guilt has also been the subject of research regarding the effectiveness of EXP. A specific
type of EXP, Prolonged Exposure (PE), is the most widely used form of EXP to treat PTSD.
Studies have demonstrated that PE can effectively produce significant reductions in measures of
trauma-related guilt (Trauma Related Guilt Inventory; TRGI; Kubany, 1996) and depression
(Rauch, Smith, & Duax, 2013); however, the specific mechanisms by which these changes occur
are unclear. Rauch and colleagues (2013) suggest that the standard PE protocol is meant to focus
on any PTSD symptoms that are distressing for the patient and that habituation to a variety of
emotions (e.g., sadness, guilt, disgust, anxiety) allows the patient to place the trauma in a broader
emotional context and re-examine the meaning of the event. Further, these researchers state that
mechanisms other than habituation that occur within other PE treatment elements may contribute
to symptom improvement. Alternatively, some theorists have suggested that significant guilt
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cognitions may interfere with habituation and may be a contraindication for EXP (Tarrier et al.,
1999). Other researchers have suggested that since EXP fosters habituation through repeated
exposure to present and future oriented fear, the retrospective nature of guilt may leave it largely
immune to the effects of habituation and EXP (Dalgleish, 2004).
Direct empirical evaluations of guilt outcomes as a result of PE are rare and have
reported mixed results. Although some studies report significant reductions in guilt as a result of
PE (Nishith et al., 2005; Oktedalen, Hoffartm, &Langkass, 2015; Resick et al., 2002; Zalta et al.,
2014), others report limited improvement in guilt and shame symptoms (Arntz et al., 2007;
Grunert, Smucker, & Weis, 2003; & Grunert et al., 2007). Furthermore, studies attempting to
augment PE with cognitive restructuring have either found no improvement over and above
traditional PE (Foa et al., 2005) or significantly worse outcomes (Moser, Cahill & Foa, 2010).
These findings suggest the potential for trauma-related cognitions to hinder the effects of PE or
that traditional treatment formats do not provide sufficient time for independent treatment
elements to be implemented sufficiently.
Studies examining the temporal order of PTSD symptom change during PE have shown
that changes in maladaptive cognitions (Zalta et al., 2014) and guilt (Oktedalen, Hoffartm, &
Langkass, 2015) precede changes in other PTSD symptoms. However, these studies were not
conducted with military or combat veterans that experience unique (Hoge et al., 2004; Litz et al.,
2009) and often multiple traumas (Kline et al., 2010). Additionally, in one of these studies, Zalta
and colleagues (2014) assessed trauma-related cognitions using the Post-Traumatic Cognitions
Inventory (PTCI; Foa et al., 2009). The PTCI assesses a variety of self-evaluative (e.g., the event
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happened because of the way I acted) as well as present fear-oriented (e.g., the world is a
dangerous place) cognitions, the latter of which may be more amenable to PE.
Certain guilt-related cognitions may respond differently to specific treatment modalities.
Steenkamp and colleagues (2015) point out that the research supporting PE’s effectiveness for
guilt examines change in guilt cognitions in assault victims and not perpetrators of violence.
Additionally, Resick and colleagues (2002) found that CPT demonstrated greater reductions than
PE in cognitions related to hindsight bias and lack of justification. This finding is in line with
existing research demonstrating that lack of justification is less related to avoidance than other
guilt related cognitions (Pugh, 2015) and also consistent with the primary theory of traumarelated guilt (Kubany, & Watson, 2003). Kubany and Watson (2003) suggest that guilt
cognitions that are associated with avoidance may be more amenable to EXP based techniques,
therefore, guilt cognitions related to a lack of justification or hindsight bias may be better
addressed by an alternative intervention. Collectively, these studies suggest that PE may not be
equally effective for all trauma or guilt-related cognitions or may not sufficiently address these
cognitions in all cases.
Although the development of PE was based on EPT and habituation, PE contains several
treatment elements in addition to exposure, including psychoeducation and emotional processing.
Psychoeducation is not unique to PE and occurs prior to the initiation of exposure techniques,
whereas emotional processing occurs after each treatment session. Proponents of PE have
suggested that although guilt stemming from morally injurious events can be acknowledged in
each element of PE, it is most notably addressed during the processing element of treatment
(Smith, Duax, & Rauch, 2013). Unfortunately, there is a clear absence of dismantling studies
9

involving PE, which limits the identification of the treatment elements responsible for reductions
in overall symptomatology and specific symptoms such as guilt.
Trauma Management Therapy (TMT) is a multicomponent treatment that includes
psychoeducation, imaginal exposure, in-vivo exposure, and group therapy. Trauma management
group therapy focuses on addressing secondary features of combat-related PTSD that are
addressed in three modules; social reintegration, anger management, and behavioral activation.
When conducted in an intensive three-week format, individual and group components are
conducted daily in two separate sessions. The anger module specifically addresses guilt during
the eighth session by discussing distorted self-blame and making reparations. TMT is a unique
treatment that achieves primary symptom reduction through EXP and targets secondary PTSD
symptoms with group therapy. TMT is distinct from PE as exposure sessions primarily target
fear and helplessness as other emotions are addressed in several additional group treatment
modules. TMT also does not emphasize the role of emotional processing after the exposure
session and post-session discussions are instead used to reinforce patient effort and positive
treatment expectancy. The absence of guilt-based emotional processing after the EXP session
provides the opportunity to assess the effects of guilt-related trauma cognitions on habituation
and overall treatment outcome. The present study will examine habituation and guilt cognitions
as time-varying predictors of treatment outcome to assess the effect of guilt cognitions on the
underlying mechanisms of EXP. Based on the PTSD treatment literature, the following
hypotheses were tested:
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1) Guilt cognitions related to acts of “commission or omission” as measured by the
CAPS will significantly improve from pre to post treatment.
2) Participants with fewer baseline self-reported guilt cognitions will achieve overall
habituation in fewer sessions than individuals with greater baseline guilt cognitions.
3) The significant reduction of avoidance symptoms will significantly contribute to the
prediction of guilt cognitions over the course of treatment.
4) Participants with greater self-reported guilt cognitions as measured by the TRGI will
demonstrate lower fear activation over the course of treatment than participants with
fewer self-reported guilt cognitions.
5) Participants with fewer self-reported guilt cognitions will demonstrate significantly
greater reductions in Peak SUDs ratings over the course of treatment.
6) A model containing Peak SUDs ratings as an index of habituation, guilt cognitions as
measured by the TRGI, and a time marker for the group guilt intervention will
demonstrate the best fit to the data predicting PTSD symptoms over the course of
treatment.
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CHAPTER TWO: METHOD
Participants
Data was collected as part of two treatment studies funded by the Department of Defense.
The Intensive TMT study evaluated the efficacy of a three-week exposure based treatment
protocol for PTSD in combat veterans and active duty personnel of OEF, OIF, and OND. The
standard 17-week study recruited a similar population and compared the efficacy of exposure
therapy with TMT group therapy to exposure therapy with traditional psychoeducation group
therapy. In the three-week protocol, patients participated in daily EXP sessions and group
therapy. Under the supervision of licensed clinical psychologists, graduate students conducted all
assessments and provided the treatment. Participants were compensated 50 dollars for
completing pre-treatment and post-treatment assessments. The sample consisted of treatmentmandated and treatment-seeking veterans as well as active-duty military personnel. Exclusion
criteria were intentionally minimized in order to obtain a representative veteran sample.
Admission into the treatment protocol required a current clinician-determined diagnosis of
combat-related PTSD confirmed by a supervising clinician. Due to the necessity for sustained
physiological arousal in the early phases of treatment, patients were excluded if they had a
history of significant cardiac symptoms. Patients were also excluded if they presented with an
acute substance abuse disorder and were unable to demonstrate two weeks of abstinence, had a
medication history that could not be stabilized for two weeks, or if the participant met criteria for
antisocial personality disorder. Although screened for Traumatic Brain Injury (TBI), a TBI
diagnosis did not exclude participants from participation in this treatment protocol as OEF, OIF,
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OND veterans experience these injuries at high rates (Shively & Perl, 2012; Vasterling,
Verfaellie, & Sullivan, 2009).
The final sample included 65 veterans and 37 active duty military personnel directly
involved in OEF, OIF or OND between the ages of 23 and 63 years. Among the sample, 57
percent reported experiencing a blast injury and 49 percent reported a history of a TBI diagnosis.
A subset of these veterans completed two measures related to guilt (See Table 1 for additional
demographics).
Intensive Trauma Management Therapy Protocol
Trauma Management Therapy (TMT) (Frueh, Turner, Beidel, Mirabella, & Jones, 1996)
is a behavioral-based treatment specifically designed to address the needs of combat veterans
diagnosed with PTSD. The original TMT protocol includes imaginal, in-vivo, and group therapy
sessions conducted over the course of 17-weeks. The group component of treatment includes six
Social Reintegration, four Anger Management, and four Behavioral Activation sessions. These
interventions target secondary features commonly associated with PTSD, but are often not
directly addressed in traditional EXP protocols (Frueh et al., 1995; Stapleton, Taylor, &
Asmundson, 2006).
The intensive TMT protocol (Beidel, Frueh, Neer, Bowers, & Rizzo, 2014) was
conducted five days a week, over the course of three weeks. Each day, patients participated in
imaginal exposure and group therapy sessions (15 individual/14 group sessions). Imaginal
exposure sessions were assisted by virtual reality (VR) equipment with visual, olfactory,
auditory, and kinesthetic cues. All or some of these cues were utilized at the discretion of the
clinician and were specific to the patient’s traumatic event. The goal of this equipment is to
13

increase the patient’s contact with the fear memory, which may promote greater fear activation
and treatment generalization.
During imaginal exposure sessions, Subjective Units of Distress (SUDS) ratings were
obtained approximately every five minutes, until the patient demonstrated a 50 percent reduction
in SUDS ratings from that sessions Peak SUDS rating, or demonstrated a return to that sessions
baseline SUDS rating (within-session habituation). If the patient demonstrated habituation to the
imaginal scene (a 50 percent reduction in Peak SUDS ratings across sessions) before the end of
the three-week protocol, the remainder of the sessions consisted of in-vivo exposure to patientspecific anxiety-provoking stimuli (e.g., large crowds). For the current analysis, only data from
the imaginal exposure sessions were examined.
Group therapy modules were co-led by two graduate clinicians and patients were
provided with daily session-related assignments to be completed outside of group. Group therapy
modules were presented in a varied order to provide the patient with sufficient time to complete
assignments and promote the integration of group content. The anger management module
included a brief one-session intervention (session 8) targeting guilt symptoms designed to reduce
distorted self-blame for a traumatic event and promote a healthy and more accurate diffusion of
this responsibility.
Measures
Clinician-Administered PTSD Scale (CAPS)
The CAPS (Blake et al., 1990; Weathers & Litz, 1994) is a 25-item semistructured interview that
assesses the DSM-IV criteria for PTSD. The CAPS includes dual (i.e., frequency and severity)
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ratings of the 17 PTSD symptoms as well as questions assessing social and occupational
impairment associated with PTSD. The CAPS interview is a clinician-assessed measure of PTSD
symptoms, and provides a reliable evaluation of the patient’s reported symptoms and functional
impairment. A total severity score (range 0-136) was calculated by summing the patient’s
endorsements. Subscale scores were calculated based on the three factors (Re-experiencing,
Avoidance, Hyperarousal) outlined in the DSM-IV. The CAPS also included two guilt-related
questions that fall under “associated features,” and assess the frequency and severity of “acts of
commission or omission” and “survivor guilt.” The CAPS interview is administered at pretreatment and one-week post treatment.
PTSD Checklist-Military Version (PCL-M)
The PCL-M (Weathers, Litz, Huska, & Keane, 1994) is a self-report measure assessing the 17
PTSD symptoms outlined in the DSM-IV with an emphasis on past military experiences. This
measure instructed patients to rate how much they “have been bothered” by their symptoms on a
Likert scale from 1 (not at all) to 5 (extremely) in the last week. A total severity score (range 085) were calculated by summing the patient’s endorsements. Subscale scores were calculated
based on the three factors (Re-experiencing, Avoidance, Hyperarousal) outlined in the DSM-IV.
The PCL-M was administered at the beginning of each week over the course of treatment and at
follow-up (one week, three months, and six months). For the purposes of this study, data was
examined from the following collection points: pre-treatment, week one, week two, week three,
and one-week post-treatment.
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Trauma-Related Guilt Inventory (TRGI)
The TRGI (Kubany, 1996) is a 32-item measure assessing three primary domains of guilt related
cognitions (Global Guilt, Distress, and Guilt Cognitions). The TRGI also provides three
additional scales (Hindsight Bias, Wrongdoing, and The Lack of Justification) comprised of
smaller groupings of items. The TRGI is the most widely used measure of trauma-related guilt
and is commonly used to assess change in cognitions over the course of PTSD treatment
(Nishith, Nixon, Resick, 2005; Oktedalen, Hoffartm, & Langkass, 2015). The TRGI was
administered at the beginning of each week over the course of treatment and at follow-up (one
week, three months, and six months). For the purposes of this study, data was examined from the
following collection points: pre-treatment, week one, week two, week three, and one-week posttreatment.
Subjective Units of Distress (SUDS)
SUDS ratings are commonly used during exposure therapy to assess acute anxiety reactions to
target stimuli. According to the TMT protocol, SUDS ratings (0, None to 8, Extreme) were
obtained approximately every five minutes until the patient demonstrated within-session
habituation. For the purposes of this protocol, within-session habituation was defined as a fifty
percent reduction from the patient's peak SUDS rating or a return to the patient’s baseline SUDS
rating. In some circumstances, sessions were ended if the time exceeded 90 minutes.
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Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
The SCID-I (First et al, 1996) is a semi-structured diagnostic interview that assesses major
psychiatric DSM-IV diagnoses. The SCID was administered to assess for comorbidities such as
depression and to confirm a diagnosis of PTSD.
Daily Behavior Rating Form (DBR)-Anxiety
The DBR-Anxiety is a measure designed for this study. From one week prior to treatment
through post treatment, participants provided daily ratings of their subjective level of general
anxiety on a Likert scale from 0 (None) to 10 (Severe).
Overall Habituation
Overall habituation was defined as the number of sessions required for the patient to achieve a
fifty percent reduction in overall peak SUDS rating.
Fear Activation
Fear activation was extracted from the patient’s session SUDS ratings and defined as the number
of minutes until the patient reaches his PEAK SUDS rating for each session. Traditionally, fear
activation is defined as the patient’s baseline SUDS rating, however; the traditional index of fear
activation (baseline SUDS rating) may not fully account for level of interference due to non-fear
related cognitions. Traditional methods (Minnen & Hagenaars, 2002) for measuring fear
activation were examined that included the participants baseline SUDS rating and a variable that
is calculated by subtracting the baseline SUDS rating from the peak suds rating.
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Statistical Strategy
For hypothesis one and two, traditional mean-based statistics were used to determine the effects
of imaginal exposure therapy on guilt-related cognitions and rate of habituation without
accounting for the effects of time. Parametric and non-parametric tests were used to assess if
guilt cognitions improve as a result of EXP and if individuals with fewer maladaptive guilt
related cognitions achieve overall habituation in fewer sessions.
1) Guilt cognitions related to acts of “commission or omission” as measured by the
CAPS will significantly improve (decrease) from pre to post treatment.
 A Wilcoxon signed-rank test was conducted to assess significant guilt
symptom reduction as a result of EXP.

2) Participants with fewer baseline self-reported guilt cognitions, as measured by the
TRGI, will achieve overall habituation in fewer sessions than individuals with greater
baseline guilt cognitions.
 A dichotomous variable (0,1) was created based on the median of the TRGI
global guilt subscale and an independent sample t-test was conducted to assess
if individuals with fewer guilt symptoms prior to treatment achieve
habituation in fewer sessions than individuals with greater guilt symptoms
prior to treatment.
Hypotheses three through six will determine if levels of guilt in this sample interfere with
the processes underlying exposure therapy and if changes in cognitive avoidance influence guilt
cognitions over the course of treatment. Mixed-effects regression allowed for the examination of
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changes in guilt and habituation over the course of treatment as well as determine if the session
eight guilt intervention significantly contributed to predicting symptom improvement. Linear
mixed-effects regression (LMER) provides many advantages over traditional ANOVA-based
methods of assessing changes over time that are particularly advantageous given the limitations
of treatment data.
Previous examinations of TMT and EXP data have revealed that the majority of symptom
improvement likely occurs in the first two weeks of treatment (Munyan, Neer & Beidel, 2014)
and that symptom severity influences the trajectory of treatment response (Currier, Holland, &
Drescher, 2014). These findings cast doubt on the ability of EXP treatment data to meet the
assumptions of ANOVA. Furthermore, repeated measures ANOVAs require complete data sets,
often leading to the creation of artificial aggregate variables, the estimation of data points, or
participant exclusion. Several factors have been shown to predict attrition during EXP (Minnen,
Arntz, & Keijsers, 2002) which suggests that there may be an underlying pattern to missing data,
violating a primary assumption of ANOVA based statistics and estimation methods. LMER
accounts for both within (random effects) and between person (fixed effects) variance. Given the
numerous advantages to LMER and the nature of treatment data, the following statistical strategy
was implemented to evaluate the following hypotheses:

3) The reduction of avoidance symptoms will significantly contribute to the prediction of
guilt cognitions over the course of treatment.
 A mixed-effects regression was conducted to assess the effects of avoidance
on the improvement in guilt symptoms. An LMER model of TRGI- Global
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Guilt subscale was constructed that includes, time, avoidance from the PCLM, and the interaction of these two terms.

4) Participants with fewer self-reported guilt cognitions will demonstrate significantly
greater reductions in Peak SUDs ratings over the course of treatment.
 A three level mixed-effects regression was conducted to assess the effects of
guilt symptoms on habituation over the course of treatment. An LMER model
of Peak SUDS was constructed that includes, time, the TRGI- Global Guilt
subscale, and the interaction of these two terms.

5) Participants with greater self-reported guilt symptoms as measured by the TRGI will
demonstrate lower fear activation over the course of treatment than participants with
fewer self-reported guilt symptoms.
 A three level mixed-effects regression was conducted to assess the effects of
guilt symptoms on fear activation over the course of treatment. An LMER
model of fear activation was constructed that includes, time, the TRGI- Global
Guilt subscale, and the interaction of these two terms.
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6) A model containing Peak SUDs ratings as an index of habituation, guilt as measured
by the TRGI, and a time marker for the group guilt intervention will demonstrate the
best fit to the data predicting PTSD symptoms over the course of treatment.
 A five level mixed-effects regression was conducted to assess the effects of
guilt symptoms, habituation, and the session eight guilt intervention on PTSD
symptoms over the course of treatment.

Data Preparation
Data was obtained from both standard (17-week) and intensive (3-week) TMT treatment
trials. Although the majority of the proposed analyses were conducted with the three-week
sample, the 17-week treatment trial was used as a point of comparison to reduce potential
treatment confounds. Individuals in the 17-week protocol received group therapy only after
completion of exposure therapy allowing the effects of exposure to be examined independently.
The sample obtained for the purposes of this study was highly representative of the current
veteran population as limited exclusion criteria were used and the active duty personnel and
veterans recruited for the TMT project are largely veterans of the OIF/OEF conflicts. For
hypotheses one and two, outliers were defined as ≥ three standard deviations from the mean of
each guilt group (high/low). For hypotheses three through six, outliers and significant leverage
cases were identified by examining individual participant plots. LMER does not require
complete data and therefore no estimation method for missing data is required.
GPower 3.0.1(Faul, Erdfelder, Lang, & Buchner, 2007) was used to calculate the
appropriate sample size for hypothesis one and two. Previous literature (Oktedalen, Hoffart, &
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Lanngkaas, 2014; Stapelton, Taylor, & Asmundson, 2006) provided a sample size estimate of d
= 0.71. With α = .05, power (1 – β) = .80 and two groups, 66 participants (33 in each group) was
needed to reliably reject the null hypothesis. Power estimates are not readily available for mixedeffects regression and therefore, the criterion of ten participants for each level of prediction was
used. For adequate power, this would require 30 participants for hypothesis three through five
and 50 participants for hypothesis six.
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CHAPTER THREE: RESULTS
Preliminary Analysis
Prior to examining the linear and non-linear mixed model trends, preliminary analyses
assessed if a significant change in guilt symptoms occurred over the course of the 3-week
intervention. At pre-treatment, TRGI- Global Guilt (TRGI-GG) scores were similar (t (40) = 1.47, p = 0.15) to that of other treatment-seeking veterans reported in previous studies (Kubany,
1996). In testing hypothesis 1, the CAPS guilt item related to acts of commission or omission
scores significantly decreased from pre-treatment to post-treatment (Mdn = 5.5, V = 206.5, p < .
D

001) as did the CAPS item related to “survivors guilt” (Mdn = 4.5, V = 62, p < .01). This
D

finding is corroborated by a more comprehensive guilt measure as the participants TRGI-GG
scores also significantly decreased from pre to post treatment (Mdn = 1.3, V = 117.5, p < .001)
D

(For M and SD see Table 2). Additionally, post-treatment TRGI-GG scores were similar (t (27) =
1.10, p = 0.28) to that of non-treatment seeking veterans (Kubany, 1996).
LMER analyses were conducted to further examine the change in guilt symptoms during
treatment. A linear mixed-model was run that included 42 participants, 87 TRGI measurements,
and assessed the effect of time (exposure session) on the TRGI subscales. Time significantly
predicted the TRGI GG (β = -.296, SE = 0.051, p < .001, r2 = .72), Guilt Cognitions (β = -.141,
SE = 0.034, p < .001, r2 = .77), and Distress (β = -.304, SE = 0.045, p < .001, r2 = .60) subscales
that were all associated with a decrease over time. As a point of comparison, the same analysis
was repeated for the 17-week participants that did not receive a group guilt intervention at any
point during the exposure portion of the protocol. In the 17-week sample, time (t = -5.08, p <
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.001, r2= .76) also significantly predicted the TRGI GG score (See Table 3) and was associated
with a similar cumulative reduction over time (β3-week = -1.2; β17-week = - .93).
To assess individual variation in the change of guilt symptoms over the course of
treatment the slope of the TRGI-GG subscale was entered as a random effect. Time remained a
significant predictor of the TRGI-GG score (t = -5.281, p <.001, r2 = .85) and was associated
with a decrease over the course of the 3-week intervention (β = -.299, SE = 0.057). The
significance of the model indicates that individuals with a higher Global Guilt score at
pretreatment demonstrated a greater rate of change than those with a lower Global Guilt score at
pretreatment (See Figure 1). However, as this model was associated with similar fit as the model
that did not include the TRGI-GG as a random effect (AICGG = 366.861; AICGG+RE = 367.889),
the more parsimonious model was carried forward for additional analyses.

Effects of Guilt on Treatment Outcome

To assess the effects of guilt on the overall treatment outcome a median split (CAPS
median = 6, TRGI-GG median = 3) was performed to create a dichotomous high and low guilt
group variable. No significant difference in the total score on the post PCL-M was found
between participants with high and low guilt based on the CAPS “acts of commission or
omission” (W = 102.5, p = 0.84) or the TRGI-GG (t = -0.286, p = 0.78) (See Table 4). Post Guilt
scores were also not significantly different between high (≥ 50 percent CAPS reduction) and
average (< 50 percent CAPS reduction) treatment responders regardless of whether guilt was
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measured by the TRGI-GG (t (6) = -0.55, p = 0.60), CAPS acts of commission or omission item
(t (11) = -0.66, p = .52) or CAPS survivors guilt item (t (16) = 0.117, p = .91).
Prior to examining the relationships between guilt and PTSD symptoms, a baseline model
of the change in PTSD symptoms over the course of the 3-week treatment was constructed. The
PCL-M included 102 participants, and 388 measurements at four time points (pre-treatment,
session 6, session 11, and post-treatment). Time significantly predicted the PCL-M (t = -16.059,
p <.001, r2 = .66) and was associated with a decrease from pre to post-treatment (β = -6.727, SE =
0.419). To assess the impact of guilt on the trajectory of PTSD symptoms, the dichotomous high
and low TRGI-GG group variable was entered into an LMER model that included time and the
interaction between time and the guilt group variable. Time (t = 25.56, p < .001), guilt group (t =
2.79. p < .01), and the interaction term (t = -2.63, p < .01) all significantly predicted the PCL-M.
The model indicated that individuals in the high guilt group tended to begin treatment with
higher PCL-M scores and improve faster (β = -9.7) over the course of treatment than individuals
in the low guilt group (β = -5.6)
Multiple LMER models assessed the effects of guilt on PTSD symptom trajectory in
addition to the effects of PTSD symptoms on guilt trajectory over the course of treatment.
Traditional LMER models compare the relationships between variables at the same time point.
For example, in a LMER model including the TRGI-GG subscale predicting the PCL-M both
time (t = -6.67, p <.001) and guilt (t = 4.25, p <.001) were significant. This model demonstrates
that these two symptoms vary together and that each change in the PCL-M is associated with a
corresponding change in the TRGI-GG (See Table 5). An alternative approach to establish the
role of each variable in predicting the other over the course of treatment is to lag one
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measurement behind by one time point so that the model represents variable x at one time point
predicting variable y at the next time point.
Lagged regression analyses were conducted to examine the causal relationship between
symptoms of PTSD and guilt over the course of treatment (See Table 6). In the first model, time
and the PCL-M score from the previous session were used as predictors of the TRGI-GG
subscale. The lagged PCL-M variable significantly predicted the subsequent TRGI score (t =
2.88, p < .01); however, time was no longer a significant predictor (t = -1.526, p =.13). For the
inverse model, the lagged TRGI-GG score (t = 2.41, p < .02) significantly predicted the
subsequent PCL-M score and time (t = -3.86, p < .001) remained a significant predictor in the
model. These results were replicated in the 17-week data (See Table 7).
To determine if these results were consistent for individuals with significant guilt
symptoms, the dichotomous high and low guilt group variables based on the TRGI-GG subscale
and CAPS guilt item were assessed with LMER models. The resulting groups for the TRGI-GG
included 25 participants in the high group and 16 participants in the low group and for the CAPS
16 in the high guilt group and 18 in the low guilt group. In the high guilt group, the results were
similar as described above (See Table 4). However, for the low group, neither the lagged PCL-M
(t = 0.222, p = .83) nor the lagged Global Guilt (t = 1.104, p = .28) models significantly
accounted for change in the other variable in the subsequent session. Despite both the high (β = 8.67, SE = 1.018, p < .001, r2 = .61) and low (β = -5.5, SE = 0.051, p < .001, r2 = .60) groups
demonstrating change over time in PTSD symptoms and guilt.
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Treatment Mechanism

Session Eight Guilt Intervention

Prior to considering the impact of guilt on specific treatment mechanisms, a discontinuity
analysis was conducted to examine the effects of the session eight guilt intervention on the
trajectory of guilt symptoms over the course of treatment. Although the reduction in guilt over
the course of treatment remained significant over time (t = 7.11, p < .01), the trajectory of guilt
was unchanged by the inclusion of the session eight-guilt intervention (β = -0.10, SE = 0.252, p =
0.69). Additionally, the interaction of time and the session eight variable (t =0.67, p = .51) did
not significantly predict the TRGI-GG subscale.

Avoidance

In testing hypothesis 3, an LMER model with 33 participants and 109 observations included time
and an avoidance change (PrePCLAvd - PostPCLAvd) score (See Table 8). Although the avoidance
change score (t = 0.387, p = .70) was not a significant predictor of the TRGI-GG subscale, time
and the interaction of time and avoidance change (t = - 2.07, p = .04) significantly predicted guilt
scores. In support of hypothesis 3, this analysis indicated that individuals with higher avoidance
change scores experienced faster changes in guilt over the course of treatment.
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Fear Activation and Habituation

To examine the treatment mechanisms of exposure therapy, LMER analyses assessed fear
activation and between–session habituation and the role of these variables in predicting treatment
outcome. On average participants received 9.6 imaginal exposure therapy sessions and 65.6
percent of participants achieved between-session habituation (50 percent reduction in Peak
SUDS rating). Over the course of treatment, time significantly predicted peak SUDS (t = -28.54,
p < .001) and fear activation (t = -4.12, p <.001) that were both associated with a decrease over
time (βPS = -0.32, βFA = -1.14). Additionally, when LMER models were run that also included
peak SUDS and fear activation as random effects, the peak SUDS model demonstrated
significantly better fit with the random effect (AICPS = 3182.12; AICPS+RE = 2890.29), whereas
the fear activation model did not demonstrate notably better fit with the random effect (AICFA =
3270.80; AICFA+RE = 3227.00). The best fitting and most parsimonious model was carried
forward for additional analyses (See Tables 8 & 9). Peak SUDS (t = 3.36, p <. 001) and fear
activation (t = 2.26, p <.05) also predicted the PCL-M score over the course of treatment and
both variables were associated with reductions in PTSD symptoms (βPS = 0.97, SE = .29; βFA =
0.41, SE = .18) (See Table 10).
With regard to guilt, 81 percent achieved habituation in the high guilt group and 60
percent achieved habituation in the low guilt group. This group proportion difference was not
significant (χ2(1) = 1.17, p = .28). In testing hypothesis 2, the high and low group did not differ
in the number of sessions required to achieve between-session habituation based on the TRGIGG (t (25) = -1.9, p = .06), CAPS acts of commission or omission (t (14) = - 1.68, p = .11) or
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CAPS survivors guilt (t (18) = 0.28, p =.78) scores. Hypothesis 4 and 5 were also not supported
as time, guilt, and the interaction were not significant predictors of fear activation or peak SUDS
ratings (See Tables 8 & 9).
In the evaluation of hypothesis 6, an LMER model was constructed that included time,
peak SUDS and the TRGI-GG subscale predicting the PCL-M over the course of treatment. The
session eight guilt variable was omitted from this analysis as prior analyses demonstrated that it
did not affect guilt trajectory. Although time (t = -2.19, p < .05) and guilt (t = 2.82, p <.02)
remained significant predictors of the PCL-M, peak SUDS (t = 0.894, p = .388) did not predict
the PCL-M over in this model.

Arousal

In the lagged PCL-M models described earlier, time no longer accounted for variability in
the TRGI-GG subscale when the lagged PCL-M score was included in the model. To investigate
further if reductions in anxious arousal predicted guilt over the course of treatment, an additional
model examined if a lagged measure of general anxiety corresponded to changes in the TRGIGG subscale over time. In this model, time (t = -2.17, p <.05) and the lagged anxiety variable (t
= 2.41, p < .05) significantly predicted the TRGI-GG score at the next session (r2 = 0.96) (See
Table 6).
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CHAPTER FOUR: DISCUSSION
The purpose of this study was to examine the changes in guilt symptoms over the course
of a three-week intensive Trauma Management Therapy Program and investigate the impact of
these symptoms on theorized mechanisms of therapeutic action. TMT is based in exposure
therapy, and unlike PE, does not teach temporary coping mechanisms (e.g., breathing retraining)
or conduct emotional processing after each session. TMT also includes several group modules
that emphasize skill building in areas (i.e., social reintegration, anger, and depression) not
adequately addressed by PE or the direct mechanisms of exposure therapy (Beidel et al., 2014;
Frueh, Turner, Beidel, Mirabella, & Jones, 1996). By basing treatment delivery directly on
flooding principles and the underlying mechanisms of exposure therapy, TMT provided a unique
opportunity to examine changes in guilt symptoms over the course of EXP without additional
confounds such as emotional processing or cognitive restructuring.
Over the course of the three-week and 17-week TMT intervention, symptoms of guilt
significantly decreased from a pre-treatment average similar to Vietnam veterans to a score
similar to non-treatment seeking veterans (Kubany, 1996). LMER analyses provided a more
thorough examination of guilt reduction over the course of treatment and revealed that the
intervention was equally effective for individuals with high and low guilt. Guilt symptoms also
did not negatively affect treatment outcome as participants with high and low guilt demonstrated
no difference in PTSD symptom reduction.
As TMT is comprised of both individual and group therapy, we examined the individual
contributions of each treatment component. Although the effects of exposure therapy were
confounded with the group intervention that occurred simultaneously during the three-week
30

treatment, results were also replicated in the 17-week protocol that did not include a co-occurring
group intervention. These analyses revealed that there was no detectable unique effect of the one
session guilt intervention and that the reduction in guilt symptoms was primarily due to exposure
therapy.
These findings are in agreement with previous literature reporting significant changes in
guilt symptoms as a result of therapeutic interventions that include exposure therapy (Nishith et
al., 2005; Oktedalen, Hoffartm, & Langkass, 2015; Resick et al., 2002; Zalta et al., 2014).
Furthermore, when taken togetherthe results of this study suggest that the reductions in guilt
reported in previous studies may be primarily due to the exposure component of PTSD treatment
and not to emotional processing or additional added treatment components.
In this study, guilt also did not inhibit the underlying mechanisms of exposure therapy.
Although both between-session habituation and fear activation were significantly related to
overall PTSD symptom reduction, guilt did not affect fear activation. Furthermore, higher guilt
scores were related to an increased rate of habituation. This finding is in the opposite direction of
the stated hypotheses and may be secondary to the greater severity of PTSD symptomatology in
the high guilt group. Participants also did not differ in the percentage that achieved betweensession habituation or in those who were classified as high treatment responders.
To further examine the relationship between symptoms of PTSD and guilt, lagged
regression analyses were conducted. The results of these analyses suggest that change in PTSD
symptoms predict change in guilt and that change in guilt symptoms predict change in PTSD
symptoms. However, in the LMER model that included lagged PTSD symptoms predicting guilt,
the effect of time (# of sessions) was not significant. This was in contrast to the lagged guilt
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model where time remained a significant predictor. Although multicollinearity cannot be ruled
out, further lagged regression analyses revealed that over the course of treatment, a participant’s
arousal (i.e., general anxiety) significantly predicted changes in guilt scores. Furthermore, greater
reductions in avoidance over the course of treatment were associated with a more rapid
improvement in guilt symptoms. Interestingly, the exposure component of treatment only
targeted avoidance of distress directly related to anxiety. These findings suggest that a reduction
in the participant’s anxiety-related distress has the secondary benefit of altering guilt attributions
associated with aversive physiological arousal. In the absence of this aversive physiological
reactivity, guilt attributions may be subjectively experienced as less distressing and less
meaningful. Additionally, directly targeting anxious arousal or general distress may allow for
greater and more efficient treatment gains (Beidel et al., 2016) that extend beyond directly
targeted mechanisms. This may also partially explain previous findings reporting reductions in
symptoms like depression in exposure therapy trials (Minnen et al., 2012; Powers et al., 2010).
This study provided a detailed examination of change processes during exposure therapy;
however, there are some limitations. Perhaps the largest limitation is due to the size of the
sample. Although, the sample size is comparable to that of other studies examining changes in
cognitions during exposure therapy (Oktedalen, Hoffartm, & Langkass, 2015; Zalta et al., 2014),
a larger sample would allow for greater generalization to diverse trauma types and symptom
presentations. Due to the expanding criteria for PTSD, the use of the DSM-IV criteria may have
biased the sample selection toward a more anxious symptom presentation. Directly targeting
anxious distress may not be possible or effective in more guilt or cognitive symptom
presentations based on newer, broader conceptualizations of PTSD. Furthermore, the study did
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not differentiate between shame and guilt, which may be theoretically distinct (Tanney et al.,
2007), and did not examine anxious related cognitions that may change differently than nonanxious cognitions over the course of therapy. Finally, the study also relied exclusively on
subjective ratings of both anxious and guilt related distress. Participants may have found it
difficult to differentiate between these two mechanisms.
The general arousal hypothesis described above may be more directly assessed with
physiological measurements. Future research should explore more concrete methods for
assessing arousal reduction during exposure therapy and the influence of this reduction on the
specific trajectories of trauma related attributions and cognitions. Future research should also
continue to explore the mechanisms of exposure therapy responsible for secondary benefits in
other non-anxiety related symptoms like shame, anhedonia, and maladaptive cognitions. For
example, a prospective dismantling study of exposure therapy would provide insight into
additional treatment mechanisms and uncover methods to increase the efficiency of efficacy
trauma focused therapies. A more thorough understanding of the mechanisms associated with
different treatment components could potentially lead to strategies to match patients with
differing treatment presentations to specific treatments. Future research should continue to look
beyond treatment outcome and explore how modifications in exposure therapy (e.g., intensive
approaches, the addition of cognitive restructuring) may alter specific symptom trajectories.
In conclusion, the current study is the first to provide evidence that guilt symptoms do not
inhibit the mechanisms of exposure therapy. Additionally, the findings of this study suggest that
the reductions in guilt symptoms reported in previous studies may be attributable to the exposure
component of treatment and subsequent reductions in avoidance rather than emotional
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processing. This study also identifies a potential exposure mechanism for a secondary benefit in
guilt symptoms as reductions in general anxiety lessen subjective aversive arousal that the
patient may no longer attribute to guilt cognitions.
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APPENDIX A: FIGURES
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Figure 1. Rate of Change and Pre-Guilt
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APPENDIX B: TABLES
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Table 1. Sample demographics

Age

Sample with
PCL-M

Sample with
TRGI

Sample with
Supplemental
CAPS

x̅ (s)
37.1 (9.1)

x̅ (s)
37 (8.2)

x̅ (s)
37.8 (8.7)

97 (95)
5 (5)

41 (98)
1 (2)

38 (97.4)
1 (2.6)

67 (65.7)
15 (14.7)
12 (11.8)
8 (7.8)

30 (71.4)
6 (14.3)
2 (4.8)
4 (9.5)

27 (69.2)
6 (15.4)
2 (5.1)
4 (10.3)

17 (16.7)
61 (59.8)
16 (15.7)
8 (7.8)

8 (19.1)
27 (64.3)
4 (9.5)
3 (7.1)

8 (20.5)
24 (61.5)
4 (10.3)
3 (7.7)

17 (16.7)
55 (53.9)
10 (9.8)
20 (19.6)

5 (11.9)
22 (52.4)
5 (11.9)
10 (23.8)

5 (12.8)
20 (51.3)
9 (23.1)
5 (12.8)

74 (72.5)
11 (10.8)
7 (6.9)
9 (8.8)
1 (≈1)

27 (64.3)
5 (11.9)
6 (14.3)
4 (9.5)
0 (0)

25 (64.1)
4 (10.3)
6 (15.4)
4 (10.3)
0 (0.0)

51 (50)
51 (50)
74.5%

18 (42.9)
24 (57.1)
68.8%

16 (41.0)
23 (59.0)
72.67%

102 (100%)

42 (100%)

39 (100%)

N (%)
Gender
Male
Female
Race
Caucasian
Hispanic
Black
Other
Education
High School Diploma
Some College
Bachelors
Graduate
Marital Status
Single
Married
Separated
Divorced
Military Branch
Army
Marines
Navy
Airforce
Coast Guard
Service Connected
Disability
Service Connected
None/Not Applicable
Average Disability %

Total
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Table 2. Pre-Post Subscale Differences
Measure
TRGI
Global Guilt**
Guilt Cognitions**
Distress***
Hindsight Bias**
Lack of Justification*
Wrongdoing**
CAPS
Item 26: Co/Omission**
Item 27: Survivor's Guilt**

Pre-Treatment
n
M
SD

Post-Treatment
n
M
SD

40
41
41
41
41
41

2.57
1.63
3.17
1.65
2.03
1.68

1.20
0.90
0.61
1.16
1.18
0.98

28
29
29
29
29
29

1.66
1.17
2.28
1.06
1.58
1.21

1.16
0.93
0.97
1.14
1.17
1.17

34
31

4.68
3.48

2.99
3.25

30
27

1.03
1.22

1.83
2.28

*Reflects significance for parametric/nonparametric tests.
P<.05*
P<.01**
P<.001***
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Table 3. Linear Mixed Effect Regression TRGI
Measure
TRGI-Global Guilt
Random Effects
σ
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
TRGI-Global Guilt with slope
parameter as RE
Random Effects
σ
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
TRGI-Guilt Cognitions
Random Effects
σ
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
TRGI-Distress
Random Effects
σ
Intercept
Time
AIC
BIC
Marginal R
Conditional R
2

2

2

2

2

2

2

2

2

2

2

2

TRGI Global Guilt 17-week
Random Effects
σ
2

β

SE

Estimate
0.413

SD
0.643

2.867
-0.296
366.861
378.482
0.076
0.715

0.198
0.051

Estimate
0.352

SD
0.593

2.877
-0.299
367.889
385.32
0.047
0.851

0.222
0.057

0.188

0.434

1.749
-1.141
280.603
292.312
0.03
0.774

0.148
0.034

11.768***
-4.106***

0.33
3.391
-0.304
320.326
332.035
0.141
0.599

0.574
0.148
0.045

22.869***
-6.773***

0.79

0.890

40

t

14.484***
-5.765***

12.939***
-5.281***

Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R

2.47
-0.133
249.110
259.985
.06
.76

2

2

0.210
0.026

11.724***
-5.08***

P<.05*
P<.01**
P<.001***

Table 4. High and Low Guilt Means and SDs for Treatment Completers.
Pre-PCL-M**
Post-PCL-M**
Measure
TRGI- Global Guilt
High
Low
CAPS
Item 26: Co/Omission
High
Low

n

M

SD

n

M

SD

16
25

69.13 9.76
60.44 10.70

14
21

40.86 12.11
43.62 14.81

16
18

67.19 11.41
60.50 9.38

13
15

44.38 16.90
40.07 10.36

P<.05*
P<.01**
P<.001***
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Table 5. PCL-M and TRGI-GG
Measure
PCL-M
Random Effects
σ2
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R2
Conditional R2
PCL-M
Random Effects
σ2
Fixed Effects
Intercept
Time
TRGI-GG
AIC
BIC
Marginal R2
Conditional R2
PCL-M
Random Effects
Time
Fixed Effects
Intercept
Time
Guilt Group
Guilt Group x Time
AIC
BIC
Marginal R2
Conditional R2

β

SE

Estimate
9.095

SD
82.716

68.034
-6.727
2997.639
3013.462
0.232
0.662

1.512
0.419

45.83

6.77

55.890
-5.423
4.423
1030.106
0.587
.36
.58

3.72
.830
1.04

7.50

2.74

64.25
- 5.55
11.20
-4.09
1182.28
1206.42
.19
.80

2.51
0.98
4.01
1.56

P<.05*
P<.01**
P<.001***
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t

45.008***
-16.059***

15.02***
-6.67***
4.247***

Table 6. Three-Week Treatment Lagged Regression Results
Measure
β
SE
t
p
TRGI-Global Guilt
Random Effects
Estimate SD
σ2
0.463
0.681
Fixed Effects
Intercept
1.269
0.660 1.925 0.060
Time
-0.16
0.108 -1.526 0.133
Lagged PCL-M
0.023
0.008 2.880 0.006
AIC
268.75
BIC
281.25
R2
.64
PCL-M
Random Effects
Estimate SD
2
σ
60.773 7.796
Fixed Effects
Intercept
52.500 4.798 10.943 <.001
Time
-4.01
1.040 -3.856 <.001
Lagged TRGI GG
2.827
1.170 2.414 0.0191
AIC
752.65
BIC
765.473
R2
.67
TRGI- Global Guilt
Random Effects
Estimate SD
σ2
.80
-.898
Fixed Effects
Intercept
2.08
.599 3.47
< .001
Time
- 0.29
.14
-2.17
< .05
Lagged Anxiety
2.827
1.170 2.414 < .05
AIC
159.04
BIC
172.42
R2
.96
P<.05*
P<.01**
P<.001***
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Table 7. Lagged Regression Results 17-Week
Measure
β
SE
t
TRGI-Global Guilt
Random Effects
Estimate SD
σ2
0.255
0.505
Fixed Effects
Intercept
0.900
0.514 1.750
Time
-0.027 0.045 -0.586
Lagged PCL-M
0.022
0.007 3.325
AIC
195.07
BIC
207.17
Marginal R2
0.135
2
Conditional R
0.749
PCL-M
Random Effects
Estimate SD
σ2
77.656 8.812
Fixed Effects
Intercept
50.263 4.749 10.583
Time
-3.199 0.643 -4.973
Lagged TRGI GG
5.450
1.367 3.986
AIC
752.650
BIC
765.473
Marginal R2
0.407
2
Conditional R
0.605
P<.05*
P<.01**
P<.001***
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p

0.085
0.560
0.002

<.001
<.001
<.001

Table 8. Peak SUDS
Measure
Peak SUDS
Random Effects
σ
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
Peak SUDS and RE
Random Effects
Time
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
Peak SUDS and RE
Random Effects
Time
Fixed Effects
Intercept
Time
Guilt
Guilt x Time
AIC
BIC
Marginal R
Conditional R
2

2

2

2

2

2

2

β

SE

Estimate
1.14

SD
1.07

7.95
-0.32
3174.89
3194.31
0.45
0.70

.13
0.01

Estimate
.05

SD
.240

8.41
-0.43
2884.11
2913.23
0.34
0.92

0.11
0.03

Estimate
.54

SD
.74

7.67
-1.07
-0.17
0.11
212.79
223.76
.22
.37

1.52
.66
.66
0.29

P<.05*
P<.01**
P<.001***
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t

59.367***
-28.54***

75.48***
-15.77***

5.05***
-1.60
-0.26
0.38

Table 9. Fear Activation
Measure
Fear Activation
Random Effects
σ
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
Fear Activation and RE
Random Effects
Time
Fixed Effects
Intercept
Time
AIC
BIC
Marginal R
Conditional R
Fear Activation
Random Effects
σ
Intercept
Time
Guilt
Guilt x Time
AIC
BIC
Marginal R
Conditional R
2

2

2

2

2

2

2

2

β

SE

1.12

1.12

3.36
-0.13
3270.80
3290.17
.10
.51

0.14
0.012

Estimate

SD

1.32

1.15

3.44
-0.15
3227.0
3256.06
.07
.60

0.17
0.02

Estimate

SD

2.8
2.917
-0.267
-0.058

1.68
1.012
0.231
0.39

199.98
209.02
.03
.13

P<.05*
P<.01**
P<.001***
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t

23.45***
-10.42***

19.92***
-7.52***

0.007
0.27
0.99

Table 10. Mechanisms Model
Measure
TRGI-GG
Random Effects
σ
Fixed Effects
Intercept
Time
Avoidance Change
Avoidance Change x time
AIC
BIC
Marginal R
Conditional R
PCL-M
Random Effects
Peak SUDS σ
2

β

SE

Estimate
1.10

SD
1.047

2.66
-0.180
0.080
-4.09

0.32
0.08
0.08
1.56

4.48

2.117

59.56
-1.291
0.975
320.326
332.035
0.141
0.599

2.390
0.841
0.290

105.5

10.27

t

8.29***
-2.36*
1.01
-2.07*

2

2

2

Fixed Effects
Intercept
Time
Peak SUDS
AIC
BIC
Marginal R
Conditional R
PCL-M
Random Effects
σ
2

2

2

Fixed Effects
Intercept
Time
Fear Activation
AIC
BIC
Marginal R
Conditional R
2

2

66.134
-1.595
.410
6453.18
6477.34
0.18
0.76

1.289
0.071
.181

P<.05*
P<.01**
P<.001***
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24.914***
-15.346***
3.358***

51.28***
-22.37***
2.259***
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